Neurogranin
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Online Inquiry
Neurogranin (Ng), a petite, neuron-specific protein, has been the subject of extensive research owing to its prospective involvement in learning and memory. Neurogranin exhibits high expression in dendritic spines of neurons, where it intricately interacts with diverse signaling molecules involved in synaptic plasticity. Consequently, in this article, we will discuss the multifaceted structure and functions of Ng, as well as its participation in sundry neurological disorders.
Structure of Neurogranin
The complex and compact structure of Neurogranin is a topic of fascination. Ng is a mere 7.6 kDa protein, encompassing 78 amino acids, and strikingly conserved across various species. This observation sheds light on the crucial role Ng plays in neuronal function. Ng's conformation exhibits a compact structure containing four α-helices and a solitary β-strand. Impressively, the N- and C-termini of Ng remain exposed, allowing for compelling interactions with other proteins, highlighting its intricate involvement in synaptic signaling mechanisms.
Applications of Neurogranin
Neurogranin, a protein with preponderance in the cerebral hemisphere, constitutes a critical mediator of synaptic plasticity, learning, and memory. Furthermore, it serves as a biological indicator for cognitive function and may have profound implications for diverse medical applications, such as drug discovery, personalized medicine, and the mitigation of neurodegenerative diseases. To elucidate the specific applications of Neurogranin, the following have been delineated:
Cognitive Function Biomarker: Neurogranin exhibits an extraordinary degree of sensitivity and specificity as a biomarker for cognitive decline and neurodegeneration, as has been evidenced in several studies. Measurement of Neurogranin is feasible both in cerebrospinal fluid (CSF) and blood, with its concentrations being elevated in patients suffering from Alzheimer's and other types of dementia. Moreover, Neurogranin has been utilized for prognostic purposes concerning cognitive deterioration and to gauge the efficacy of therapeutic interventions in cases of neurodegeneration.
Drug Development: Multiple neurological disorders, including Alzheimer's disease, schizophrenia, and depression, hold Neurogranin as a promising target for drug development. The pharmacological intervention by targeting Neurogranin may enhance synaptic plasticity, improve learning and memory, and ameliorate cognitive deficits characteristic of these diseases.
Personalized Medicine: The use of Neurogranin as a biomarker might serve to identify individuals vulnerable to cognitive decline and neurodegeneration. Consequently, it would enable early identification and intervention in a patient-centered treatment plan. The measurement of Neurogranin in CSF or blood could assist clinicians in identifying patients who would benefit from cognitive training, lifestyle modifications, or drug therapies.
Basic Research: Neurogranin constitutes a crucial protein in basic research to unravel the mechanisms of synaptic plasticity and memory formation. By studying the function of Neurogranin in the brain, researchers can gain a deep understanding of the underlying causes of cognitive decline and design innovative approaches to manage neurological disorders.
